ABSTRACT
Modern moleculargenetic methods of tuberculosis diagnosis have higher sensitivity and specificity compared to traditional methods, and allow to quickly detect the presence of tuberculosis mycobacteria in biosubstrates, their resistance to drugs, and timely selection and correction of treatment according to the type of mutation detected, increase the effectiveness of treatment, reduce the duration of ablation of patients and Mycobacterium tuberculosis makes it possible to prevent the spread of drugresistant strains.
Keywords: tuberculosis, mycobacterium tuberculosis, drug resistance, molecular genetic methods

---

REFERENCES

1. 18-й Доклад о глобальной борьбе с туберкулезом - ВОЗ, 2013.
2. Старшинова А.А., Павлова М.В., Довгалюк И.Ф., Журавлев В.Ю. Иммунологические и молекулярно-генетические методы диагностики туберкулеза. – Инновационные технологии во фтизиатрии и пульмонологии / Научная сессия ФГБУ СПб НИИ фтизиопульмонологии, 5.04.2013г. – СПб.: 2013. – Доклад-презентация, 26 с
3. Miotto, P et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis // European Respiratory Journal 50.6 (2017): 1701354.
4. Nathavitharana RR, et al. 2017. Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta- analysis // Eur Respir J 49.
5. World Health Organization. (2008). Molecular line probe assay for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy statement. World Health Organization
6. Theron G, et al. 2016. GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. Cochrane Database Syst Rev 9:CD010705).